...BRCA1 and BRCA2. Several observational studies have suggested that contralateral risk-reducing mastectomy, following a d...
...BRCA1/2 among patients who meet evidence-based practice guidelines for BRCA1/2 testing, with a high rate (15-88%) of uni...
...BRCA1 mutations has precluded assignment of BRCA1 as a definitive Fanconi anemia susceptibility gene. Here, we report th...
...BRCA1 and/or BRCA2 mutation as well as other patient groups at increased breast cancer risk. This option should be offer...
...Brca1), Rad 51 homolog (Rad51), poly [ADP-ribose] polymerase 1 (Parp1) and protein kinase, DNA-activated, catalytic poly...
...BRCA1) were analyzed in 327 tissue samples from lung, rectal, colon, gastric, esophageal, and breast tumors. According t...
...BRCA1 were discovered and deemed as the first genetic predisposition for the disease in 1994. By now, genetic predisposi...
...BRCA1/2 mutation screening, and BRCA1 promoter methylation data.,BRCA1/2 deleterious mutations were observed in all brea...
...BRCA1 187delAG, BRCA1 5385insC, and BRCA2 6174delT) is therefore recommended for all AJ breast and ovarian cancer patien...
...BRCA1 in DNA damage response), networks (i.e. cell cycle) and biological processes (i.e. cell division process of chromo...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2026.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
